RE:Ccabbott Lazard as a licensing deal for ryplasim how muchedrose wrote: Is that worth
re checkpoints for ryplasim stated all the time and hard work re chemistry is done so submitting bla very soon will be more positive news
last year lost 238 million. They took down accounting practice of 150 million re ivig
2019 cut r&d by 30 million
one time plasma sale of around 14 million with offers they did not consider plus atm plus eg salp converts only 100 million not 228 million we have lots of money
re consonance IF THEY DONT PUBLICLY STATES THEY WILL NOT PARTICIPATE IN OFFERING ASK YOURSELF WHY
edrose I don't know what kind of deal or partnership Prometic will be able to secure via Lazard.
With regards to Consonance, they are a new tute investor of Prometic, it's
not a common practice for a third party to issue any NR with regards to their own investment stragegy to Prometic's shareholders. For me, I don't think that they will take part in the rights, but I understand that many here may hold a different view.